activins has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajithdoss, D; Boyapati, A; Ehmann, PJ; Gadi, A; Glass, DJ; Hamon, SC; Kyratsous, CA; McAleavy, M; Morton, LG; Oyejide, A; Pan, L; Shavlakadze, T; Simonson, R; Wakai, M; Wipperman, MF; Xu, J; Zhang, Q | 1 |
| Boumpas, DT; Divolis, G; Gavriil, A; Gavriilidis, E; Germanidis, G; Kalra, B; Kumar, A; Loli, G; Metallidis, S; Papadopoulos, V; Pasternack, A; Rafailidis, P; Ritvos, O; Sertaridou, E; Sideras, P; Skendros, P; Synolaki, E; Tsahouridou, O; Tsigalou, C; Tziolos, NR | 1 |
1 trial(s) available for activins and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
The Activin/FLRG Pathway Associates with Poor COVID-19 Outcomes in Hospitalized Patients.
Topics: Activins; Adult; Aged; Animals; Antibodies, Monoclonal, Humanized; Cell Line; Cells, Cultured; COVID-19; COVID-19 Drug Treatment; Cricetinae; Double-Blind Method; Female; Follistatin-Related Proteins; Hospitalization; Humans; Male; Middle Aged; Outcome Assessment, Health Care; SARS-CoV-2; Severity of Illness Index; Signal Transduction; Survival Rate | 2022 |
1 other study(ies) available for activins and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
The Activin/Follistatin Axis Is Severely Deregulated in COVID-19 and Independently Associated With In-Hospital Mortality.
Topics: Activins; Aged; Biomarkers; Cohort Studies; COVID-19; Decision Support Techniques; Female; Follistatin; Greece; Hospital Mortality; Humans; Male; Middle Aged; Retrospective Studies; SARS-CoV-2 | 2021 |